Company Performance Metrics
Biosysion develops molecular diagnostic solutions focused on early detection and management of cancer and other critical diseases. The company offers in vitro diagnostic devices, automated PCR systems, chemiluminescence analyzers, and AI-powered ultrasound imaging tools for clinical and point-of-care use. Its portfolio includes home testing kits
such as ColoCam Tube self-test FIT kits and ColoCam-DX systems for colorectal and gastrointestinal screening. Biosysion also provides disease-specific assays and detection kits for cardiac, bone, inflammatory, infectious, and other conditions. In addition to hardware and reagents, it supports clinicians, laboratories, and healthcare providers with validation, technical training, and diagnostic workflow integration. These solutions are used by clinical labs, hospitals, telemedicine providers, and partners working in oncology, respiratory disease, cardiovascular health, and tuberculosis diagnostics.